Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Immix Biopharma, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −2 vs. Q4 2021
- Shares held
- 146.5K
- −1.37M (−90.4%) vs. Q4 2021
- Total value
- $352.0K
- −$5.05M (−93.5%) vs. Q4 2021
- New holders
- 7
- 0 more added
- Sold out
- 9
- 1 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 109 | $579.6M |
| Q1 2026 | 77 | $246.6M |
| Q4 2025 | 67 | $127.5M |
| Q3 2025 | 31 | $5.78M |
| Q2 2025 | 23 | $4.68M |
| Q1 2025 | 22 | $4.90M |
| Q4 2024 | 23 | $6.32M |
| Q3 2024 | 25 | $6.10M |
| Q2 2024 | 31 | $8.77M |
| Q1 2024 | 35 | $15.7M |
| Q4 2023 | 28 | $5.32M |
| Q3 2023 | 16 | $1.39M |
| Q2 2023 | 18 | $1.75M |
| Q1 2023 | 12 | $729.8K |
| Q4 2022 | 18 | $1.01M |
| Q3 2022 | 12 | $406.0K |
| Q2 2022 | 7 | $475.0K |
| Q1 2022 | 8 | $352.0K |
| Q4 2021 | 11 | $5.47M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Immix Biopharma, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 62,600 | $151.0K | 0.00% | +62,600 | New |
| Virtu Financial LLC | 23,515 | $57.0K | 0.00% | +23,515 | New |
| Citadel Advisors LLC | 21,713 | $52.0K | 0.00% | −4,761−18.0% | Reduced |
| InterOcean Capital Group, LLC | 15,900 | $38.0K | 0.00% | +15,900 | New |
| XTX Topco Ltd | 12,992 | $31.0K | 0.01% | +12,992 | New |
| BlackRock Inc. | 9,415 | $22.0K | 0.00% | +9,415 | New |
| Advisor Group Holdings, Inc. | 350 | $1.00K | 0.00% | +350 | New |
| Wells Fargo & Company | 26 | $0 | 0.00% | +26 | New |
| Murchinson Ltd. | 0 | $0 | 0.00% | −695,600−100.0% | Sold out |
| Lynwood Capital Management Inc. | 0 | $0 | 0.00% | −565,297−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −122,388−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −32,649−100.0% | Sold out |
| Eidelman Virant Capital | 0 | $0 | 0.00% | −29,856−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −20,470−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,173−100.0% | Sold out |
| Context Capital Management, LLC | 0 | $0 | 0.00% | −11,532−100.0% | Sold out |
| Clear Street LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| PVG Asset Management Corp | – | – | – | – | Not filed |